News

Projected Growth of US Plasma Fractionation Market Dynamics

Projected Growth of US Plasma Fractionation Market Dynamics

Insights into the US Plasma Fractionation Market Growth

The US plasma fractionation market is on a significant upward trajectory, with projections estimating its value to reach approximately US$13.80 billion by the year 2028. This growth, occurring at a compound annual growth rate (CAGR) of 6.4%, is attributed to a combination of factors including increased utilization of immunoglobulins and strategic expansion of plasma collection centers.

Market Drivers and Dynamics

One of the main drivers of this market is the rising application of immunoglobulins across various therapeutic areas. These components are pivotal in treating a range of immunological and neurological conditions. Specifically, their use has surged in response to the growing incidences of respiratory diseases such as chronic obstructive pulmonary disease and alpha-1-antitrypsin deficiency.

Additionally, market players are strategically enhancing their infrastructure by expanding plasma collection centers and inventories, which bolsters the supply chain and ensures a steady availability of these vital therapeutic products.

Product Segmentation in the Market

The US plasma fractionation market can be categorized into several product types, including immunoglobulins, albumins, coagulation factor concentrates, and protease inhibitors, among others. Notably, immunoglobulins held the largest share of the market in 2022, significantly owing to the rise in cases related to immune system disorders. The versatility of immunoglobulins makes them indispensable in therapeutic protocols addressing conditions such as immune thrombocytopenic purpura and Kawasaki syndrome.

Immunoglobulin Segment Growth

The immunoglobulin segment is projected to see the highest growth volume due to its broad range of medical applications, including treatments for autoimmune diseases and primary immunodeficiency disorders. This broad spectrum leads to higher demand, ensuring that immunoglobulins will likely be at the forefront of the plasma fractionation market's expansion.

Applications Driving Market Demand

Diving deeper into application areas, the US plasma fractionation market is further segmented into critical fields like pulmonology, immunology, hematology, and neurology. Among these, the pulmonology sector is expected to witness the highest CAGR during the forecast period. This increase is largely driven by the effectiveness of immunoglobulins in managing respiratory infections.

Role of Protease Inhibitors

Moreover, the utilization of protease inhibitors, such as alpha-1-antitrypsin, has also seen notable uptake in recent years due to its promise in treating various ailments, adding to the market's growth potential.

Industry Players and Competitive Landscape

Key participants in the plasma fractionation market, such as ADMA Biologics and Emergent BioSolutions, play a crucial role in shaping industry trends through innovative solutions and strategic partnerships. Their efforts not only enhance operational efficiencies but also contribute significantly to the overall growth of the market.

Conclusion: Future Prospects

The US plasma fractionation market is poised for substantial growth driven by a variety of factors, including the geographical expansion of plasma collection sites and increased manufacturing capabilities. As the healthcare landscape continues to evolve, the demand for plasma-derived products will likely remain robust.

Frequently Asked Questions

What is the projected value of the US plasma fractionation market by 2028?

The US plasma fractionation market is projected to reach approximately US$13.80 billion by 2028.

What is the CAGR for the US plasma fractionation market?

The market is expected to grow at a CAGR of 6.4% during the forecast period.

Which segment held the largest share of the market in 2022?

Immunoglobulins accounted for the largest share of the US plasma fractionation market in 2022.

What applications are driving the growth of the plasma fractionation market?

Segments such as pulmonology, immunology, and hematology are key applications driving market growth.

Who are the prominent players in the US plasma fractionation market?

ADMA Biologics and Emergent BioSolutions are among the key players in this market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

Adia Nutrition Showcases Artistry to Inspire Healing Journey

Updated Category News Views 294

Adia Nutrition Introduces Inspiring Art at Their Clinic Adia Nutrition has made a significant splash in the healthcare world with the addition of a captivating artwork by the celebrated performance artist Rock Demarco. This unique piece graces the main reception area of the clinic and embodies a powerful message of transformation and rebirth. Infused with the imagery of...

Continue Reading
Civitas Capital Group Begins Major Multifamily Development

Updated Category News Views 227

Civitas Capital Group Advances Housing Solutions Civitas Capital Group, a dynamic investment firm based in Dallas, is making significant strides in addressing the growing demand for housing in the market. Recently, the company has successfully broken ground on a 76-unit Class A multifamily community that promises to enhance living conditions and activate the local...

Continue Reading
South Street Securities Reforestation: A Legacy for the Planet

Updated Category News Views 136

Celebrating Continuous Commitment to Reforestation Every year, as Earth Day approaches, South Street Securities Holdings, Inc. rejoices in its ongoing dedication to reforestation efforts. Their collaboration with Evertreen shows real commitment to tackling climate change and fostering environmental sustainability. Impactful Tree Planting Across Continents South Street’s...

Continue Reading
Amwins Enhances Underwriting Strategy with New Initiatives

Updated Category News Views 141

Amwins Strengthens International Underwriting Capabilities Amwins Global Risks (AGR), a leader in specialty insurance solutions, has introduced an innovative structure aimed at amplifying its underwriting prowess and capacity. Jack Bryan has stepped into a significant role, spearheading the Marine Cargo product line under the new MGA Contour Underwriting initiative. This...

Continue Reading
Eaton Corp: Analyzing Recent Options Activity and Market Trends

Updated Category News Views 244

Eaton Corp: Analyzing Recent Options Activity and Market Trends Investor sentiment around Eaton Corp (ETN) has taken a notable turn, with some calling for caution. There has been a significant spike in bearish options activity that savvy market players cannot overlook. This trend has sparked discussions about potential market movements and what they imply for the...

Continue Reading